HKSE proposes to expand listing eligibility for biotechs

Hong Kong Exchanges and Clearing Ltd. (HKEX) said Friday that it will amend its listing rules to allow pre-revenue biotechs and companies from emerging and innovative sectors with weighted voting rights (WVR) structures to list on

Read the full 364 word article

User Sign In